From: Primary breast lymphoma of childhood: a case report and review of literature
Reference | Age/Sex | Side | Size (cm) | Stage | Histology | Treatment | Outcome (from onset) |
---|---|---|---|---|---|---|---|
Dixon et al. 1987 [9] | 17y/F | NA | 2 | NA | NHL unclassified | Surgery + RT | CR, 25 years |
Boothroyd et al. 1994 [10] | 11y/F | Right | NA | NA | B-cell NHL | CT | CR, 36 months |
Rogers et al. 1994 [11] | 14y/F | NA | 8 x 7 | IIE | LBL | CT | CR |
Aguilera et al. 2000 [12] | 13y/F | Left | 6 x 6 | IE | ALCL ALK + | Surgery | Dead |
Barista et al. 2000 [13] | 17y/F | Right | NA | IIE | DLBCL | CHOP + RT | CR, 57 months |
Abdullah et al. 2004 [14] | 15y/F | Left | 5 | IE | ALCL ALK + | CT (cyclophosphamide, prednisolone) | CR, 22 years |
Lingohr et al. 2009 [15] | 12y/F | Bilateral | NA | NA | BL | Surgery | Dead |
Daneshbod et al. 2010 [16] | 16y/F | Right | NA | IIE | ALCL ALK + | CHOP | Dead |
Ishizuka et al. 2020 [17] | 14y/F | Right | 4 | IE | LBL | CT (ALL, not specified trial) | CR, 8 months |
Charfi et al. 2020 [18] | 16y/F | Left | NA | IIE | ALCL ALK + | CT (doxorubicin, bleomycin, vincristine, dacarbazine) | CR, 24 months |
Oral et al. 2021 [19] | 11y/M | Right | 3.5 x 1.7 | IE | LBL | Surgery | NA |
Our case | 15y/F | Right | 6.5 | IIE | DLBCL | CT (AIEOP LNH-97 trial) | CR, 20 months |